IN201641026603A - - Google Patents

Info

Publication number
IN201641026603A
IN201641026603A IN201641026603A IN201641026603A IN201641026603A IN 201641026603 A IN201641026603 A IN 201641026603A IN 201641026603 A IN201641026603 A IN 201641026603A IN 201641026603 A IN201641026603 A IN 201641026603A IN 201641026603 A IN201641026603 A IN 201641026603A
Authority
IN
India
Application number
IN201641026603A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN201641026603A priority Critical patent/IN201641026603A/en
Publication of IN201641026603A publication Critical patent/IN201641026603A/en

Links

IN201641026603A 2016-08-04 2016-08-04 IN201641026603A (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN201641026603A IN201641026603A (https=) 2016-08-04 2016-08-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201641026603A IN201641026603A (https=) 2016-08-04 2016-08-04

Publications (1)

Publication Number Publication Date
IN201641026603A true IN201641026603A (https=) 2018-02-09

Family

ID=87975954

Family Applications (1)

Application Number Title Priority Date Filing Date
IN201641026603A IN201641026603A (https=) 2016-08-04 2016-08-04

Country Status (1)

Country Link
IN (1) IN201641026603A (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114214375A (zh) * 2021-12-27 2022-03-22 江苏威凯尔医药科技有限公司 (r)-3-(4-卤代-1h-吡唑-1-基)-3-环戊基丙酸酯的制备方法
US11897889B2 (en) 2020-08-18 2024-02-13 Incyte Corporation Process and intermediates for preparing a JAK1 inhibitor
US11905292B2 (en) 2020-08-18 2024-02-20 Incyte Corporation Process and intermediates for preparing a JAK inhibitor
US12071439B2 (en) 2021-07-12 2024-08-27 Incyte Corporation Process and intermediates for preparing a JAK inhibitor

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11897889B2 (en) 2020-08-18 2024-02-13 Incyte Corporation Process and intermediates for preparing a JAK1 inhibitor
US11905292B2 (en) 2020-08-18 2024-02-20 Incyte Corporation Process and intermediates for preparing a JAK inhibitor
US12428426B2 (en) 2020-08-18 2025-09-30 Incyte Corporation Process and intermediates for preparing a JAK1 inhibitor
US12479851B2 (en) 2020-08-18 2025-11-25 Incyte Corporation Process and intermediates for preparing a JAK inhibitor
US12071439B2 (en) 2021-07-12 2024-08-27 Incyte Corporation Process and intermediates for preparing a JAK inhibitor
CN114214375A (zh) * 2021-12-27 2022-03-22 江苏威凯尔医药科技有限公司 (r)-3-(4-卤代-1h-吡唑-1-基)-3-环戊基丙酸酯的制备方法
WO2023125373A1 (zh) * 2021-12-27 2023-07-06 江苏威凯尔医药科技有限公司 芦可替尼及其中间体的制备方法
CN114214375B (zh) * 2021-12-27 2024-03-19 江苏威凯尔医药科技有限公司 (r)-3-(4-卤代-1h-吡唑-1-基)-3-环戊基丙酸酯的制备方法

Similar Documents

Publication Publication Date Title
CH714036A1 (https=)
BR122021017409A2 (https=)
BR112019002665A2 (https=)
BR112019009263A2 (https=)
BR112018004966A2 (https=)
BR112019009262A2 (https=)
BR112019008087A2 (https=)
BR202017015425U2 (https=)
BR112019009373A2 (https=)
BR202016021748U2 (https=)
BE2016C010I2 (https=)
CN303536106S (https=)
CN303537567S (https=)
CN303536127S (https=)
CN303536212S (https=)
CN303536216S (https=)
CN303536221S (https=)
CN303536278S (https=)
CN303536284S (https=)
CN303536357S (https=)
CN303536361S (https=)
CN303536428S (https=)
CN303536593S (https=)
CN303536597S (https=)
CN303536736S (https=)